van Uden Renate C A E, Bakker Marit A, Joosten Stephan G L, Meijer Karina, van den Bemt Patricia M L A, Becker Matthijs L, Vervloet Marcia
Pharmacy Foundation of Haarlem Hospitals, Boerhaavelaan 24, 2035 RC Haarlem, The Netherlands.
Department of Clinical Pharmacy, Spaarne Gasthuis Hospital, Boerhaavelaan 22, 2035 RC Haarlem, The Netherlands.
Pharmacy (Basel). 2023 Apr 27;11(3):80. doi: 10.3390/pharmacy11030080.
For several indications or combinations of indications the use of more than one antithrombotic agent is required. The duration of combined antithrombotic therapy depends on indication and patient characteristics. This study investigated the use of an antithrombotic questionnaire tool that had been developed for pharmacists to detect patients with possible incorrect combined antithrombotic therapy. The objective of this study was to identify potential barriers and facilitators that could influence the implementation of the developed antithrombotic questionnaire tool in daily community pharmacy practice. A qualitative study was conducted at 10 Dutch community pharmacies in which the antithrombotic questionnaire tool had been used with 82 patients. Semi-structured interviews were conducted with pharmacy staff who used the antithrombotic questionnaire tool. The interview questions to identify barriers and facilitators were based on the Consolidated Framework for Implementation Research. The interview data were analysed using a deductive thematic analysis. Ten staff members from nine different pharmacies were interviewed. Facilitators for implementation were that the questionnaire was easily adaptable and easy to use, as well as the relative short duration to administer the questionnaire. A possible barrier for using the questionnaire was a lower priority for using the questionnaire at moments when the workload was high. The pharmacists estimated that the questionnaire could be used for 70-80% of the patient population and they thought that it was a useful addition to regular medication surveillance. The antithrombotic questionnaire tool can be easily implemented in pharmacy practice. To implement the tool, the focus should be on integrating its use into daily activities. Pharmacists can use this tool in addition to regular medication surveillance to improve medication safety in patients who use combined antithrombotic therapy.
对于几种适应症或适应症的组合,需要使用一种以上的抗血栓形成药物。联合抗血栓形成治疗的持续时间取决于适应症和患者特征。本研究调查了一种为药剂师开发的抗血栓形成问卷工具的使用情况,以检测可能接受不正确联合抗血栓形成治疗的患者。本研究的目的是确定可能影响所开发的抗血栓形成问卷工具在社区药房日常实践中实施的潜在障碍和促进因素。在10家荷兰社区药房进行了一项定性研究,其中对82名患者使用了抗血栓形成问卷工具。对使用抗血栓形成问卷工具的药房工作人员进行了半结构化访谈。用于识别障碍和促进因素的访谈问题基于实施研究综合框架。使用演绎主题分析法对访谈数据进行了分析。对来自9家不同药房的10名工作人员进行了访谈。实施的促进因素包括问卷易于调整且易于使用,以及问卷管理的相对较短时间。使用问卷的一个可能障碍是在工作量大的时候使用问卷的优先级较低。药剂师估计该问卷可用于70%-80%的患者群体,他们认为这是对常规药物监测的有益补充。抗血栓形成问卷工具可以很容易地在药房实践中实施。为了实施该工具,重点应放在将其使用融入日常活动中。药剂师除了进行常规药物监测外,还可以使用该工具来提高接受联合抗血栓形成治疗患者的用药安全性。